Legend Biotech Corp Adjustments For Decrease Increase In Inventories
Legend Biotech Corp (LEGN) reported Adjustments For Decrease Increase In Inventories of -$4.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Inventory
ifrs-full:AdjustmentsForDecreaseIncreaseInInventories · last filed 2026-03-10
- Legend Biotech Corp adjustments for decrease increase in inventories for the quarter ending 2025-12-31 was -$3.85M.
- Legend Biotech Corp adjustments for decrease increase in inventories for the quarter ending 2025-09-30 was $5.37M.
- Legend Biotech Corp adjustments for decrease increase in inventories for the quarter ending 2025-06-30 was -$2.79M.
- Legend Biotech Corp adjustments for decrease increase in inventories for the quarter ending 2025-03-31 was -$3.23M.
| Period end | Adjustments For Decrease Increase In Inventories 3 month | Adjustments For Decrease Increase In Inventories 6 month | Adjustments For Decrease Increase In Inventories 6 month as first filed | Adjustments For Decrease Increase In Inventories 9 month | Adjustments For Decrease Increase In Inventories 9 month as first filed | Adjustments For Decrease Increase In Inventories 12 month | Adjustments For Decrease Increase In Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$3.85M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $1.52M derived: sum of 2 quarters · filed 2026-03-10 | -$1.27M derived: sum of 3 quarters · filed 2026-03-10 | -$4.50M 20-F · filed 2026-03-10 | |||
| 2025-09-30 | $5.37M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $2.58M derived: sum of 2 quarters · filed 2025-11-12 | -$647.00K 6-K · filed 2025-11-12 | -$6.90M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2025-06-30 | -$2.79M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | -$6.02M 6-K · filed 2025-08-11 | -$12.28M derived: sum of 3 quarters · filed 2026-03-10 | -$17.36M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2025-03-31 | -$3.23M 6-K · filed 2025-05-13 | -$9.49M derived: sum of 2 quarters · filed 2026-03-10 | -$14.57M derived: sum of 3 quarters · filed 2026-03-10 | -$15.96M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-12-31 | -$6.26M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$11.34M derived: sum of 2 quarters · filed 2026-03-10 | -$12.73M derived: sum of 3 quarters · filed 2026-03-10 | -$17.20M 20-F · filed 2026-03-10 | -$17.21M 20-F · filed 2025-03-11 | ||
| 2024-09-30 | -$5.08M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -$6.47M derived: sum of 2 quarters · filed 2025-11-12 | -$10.94M 6-K · filed 2025-11-12 | -$14.64M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-06-30 | -$1.39M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | -$5.86M 6-K · filed 2025-08-11 | -$9.56M derived: sum of 3 quarters · filed 2026-03-10 | -$13.14M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-03-31 | -$4.47M 6-K · filed 2025-05-13 | -$8.17M derived: sum of 2 quarters · filed 2026-03-10 | -$11.75M derived: sum of 3 quarters · filed 2026-03-10 | -$15.00M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2023-12-31 | -$3.70M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$7.28M derived: sum of 2 quarters · filed 2026-03-10 | -$10.53M derived: sum of 3 quarters · filed 2026-03-10 | -$12.70M 20-F · filed 2026-03-10 | -$12.71M 20-F · filed 2024-03-19 | ||
| 2023-09-30 | -$3.58M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$6.83M derived: sum of 2 quarters · filed 2024-11-12 | -$9.00M 6-K · filed 2024-11-12 | -$7.66M 6-K · filed 2023-11-20 | -$14.22M derived: sum of 4 quarters · filed 2025-03-11 | ||
| 2023-06-30 | -$3.25M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | -$5.42M 6-K · filed 2024-08-09 | -$4.84M 6-K · filed 2023-08-15 | -$10.63M derived: sum of 3 quarters · filed 2025-03-11 | -$12.90M derived: sum of 4 quarters · filed 2025-03-11 | ||
| 2023-03-31 | -$2.17M 6-K · filed 2024-05-13 | -$7.39M derived: sum of 2 quarters · filed 2025-03-11 | -$9.66M derived: sum of 3 quarters · filed 2025-03-11 | ||||
| 2022-12-31 | -$5.21M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | -$7.48M derived: sum of 2 quarters · filed 2025-03-11 | -$13.89M 20-F · filed 2025-03-11 | -$8.61M 20-F · filed 2023-03-30 | |||
| 2022-09-30 | -$2.27M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | -$8.68M 6-K · filed 2023-11-20 | |||||
| 2022-06-30 | -$6.41M 6-K · filed 2023-08-15 | ||||||
| 2021-12-31 | $51.00K 20-F · filed 2024-03-19 | ||||||
| 2021-06-30 | $94.00K 6-K · filed 2021-08-23 | ||||||
| 2020-12-31 | -$643.00K 20-F · filed 2023-03-30 | ||||||
| 2020-06-30 | -$511.00K 6-K · filed 2021-08-23 | ||||||
| 2019-12-31 | -$22.00K 20-F/A · filed 2023-02-17 | ||||||
| 2018-12-31 | -$1.12M 20-F · filed 2021-04-02 |